Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Dry eye syndrome is caused by a chronic lack of sufficient lubrication and moisture on the surface of the eye. Consequences of dry eyes range from subtle but constant eye irritation to significant inflammation and even scarring of the front surface of the eye. Furthermore, in Europe, dry eye syndrome affects patients of all ages and both sexes. Although the prevalence increases with ageing population in developed countries, the numbers of subjects with dry eye syndrome is expected to increase substantially. In addition to a contemporary lifestyle, ageing population, rising number of consumers becoming concerned about their health, rising prevalence of allergies among the European population and growing penetration of digital devices, including laptops and smartphones, which are increasing eye irritation are some of the factors expected to fuel the dry eye syndrome market in Europe.
Growing number of eye care centers, technological advancements in Europe dry eye syndrome therapeutics, High prevalence and rise in incidence rates of dry eye disease are some the major factors driving the growth of the Europe dry eye syndrome therapeutics market. On the other hand, factors such as alternative therapies and high cost of specialty dry eye products are hampering the growth of the market.
The Europe dry eye syndrome therapeutics market is segmented by product type, disease type and country.
Based on product type, European dry eye syndrome therapeutics market are cyclosporine, oral corticosteroid, artificial tears, omega supplements, punctal plugs and others. Furthermore, punctual plugs segment is classified into removable and dissolvable. Likewise, others segment include lid wipes, eye mask and specialized eye wares. Among various product types, the cyclosporine dominated the Europe dry eye syndrome therapeutics market in 2018 and is also projected to lead the market by 2025. There are few alternatives which are as effective as cyclosporine which is helping the drug to hold strong dominance in the market.
The various disease types of Europe dry eye syndrome therapeutics market are covered in the report such as evaporative dry eye syndrome and aqueous dry eye syndrome. The aqueous dry eye syndrome segment accounted for the largest market share in 2018. This syndrome is caused by the tear gland damage, increase in the age and when the lacrimal gland fails to produce enough tears to coat the surface of the eye. Whereas, the market for evaporative dry eye syndrome is also projected to increase rapidly.
The Europe dry eye syndrome therapeutics market report includes market size estimation & forecast for the regions such as the United Kingdom, France, Germany, Italy and Rest of Europe. The market of Europe was dominated by Germany. The strong performance of eye care markets such as standard and allergy eye care are recorded in Germany, due to the growing number of consumers being affected by dry eye, rising prevalence of allergies among the German population and growing population.
The Europe dry eye syndrome therapeutics market report includes market size estimation & forecast for the regions such as the United Kingdom, France, Germany, Italy and Rest of Europe. The market of Europe was dominated by Germany. The strong performance of eye care markets such as standard and allergy eye care are recorded in Germany, due to the growing number of consumers being affected by dry eye, rising prevalence of allergies among the German population and growing population.
The Europe dry eye syndrome therapeutics market is segmented by product type, disease type and geography. Based on product type, European dry eye syndrome therapeutics market are cyclosporine, oral corticosteroid, artificial tears, omega supplements, punctal plugs and others. Furthermore, punctual plugs segment is classified into removable and dissolvable. Likewise, others segment include lid wipes, eye mask and specialized eye wares. Among various product types, the cyclosporine dominated the Europe dry eye syndrome therapeutics market in 2018 and is also projected to lead the market by 2025. There are few alternatives which are as effective as cyclosporine which is helping the drug to hold strong dominance in the market.
The various disease types of Europe dry eye syndrome therapeutics market are covered in the report such as evaporative dry eye syndrome and aqueous dry eye syndrome. The aqueous dry eye syndrome segment accounted for the largest market share in 2018. This syndrome is caused by the tear gland damage, increase in the age and when the lacrimal gland fails to produce enough tears to coat the surface of the eye. Whereas, the market for evaporative dry eye syndrome is also projected to increase rapidly.
Geographically, Europe dry eye syndrome therapeutics market is studied across the countries of Europe. The report includes market size estimation & forecast for the regions such as the United Kingdom, France, Germany, Italy and Rest of Europe. The market of Europe was dominated by Germany. The strong performance of eye care markets such as standard and allergy eye care are recorded in Germany, due to the growing number of consumers being affected by dry eye, rising prevalence of allergies among the German population and growing population.
Why to buy this report:
